dc.contributor.author | Nugawela, MD | en_US |
dc.contributor.author | Gurudas, S | en_US |
dc.contributor.author | Prevost, AT | en_US |
dc.contributor.author | Mathur, R | en_US |
dc.contributor.author | Robson, J | en_US |
dc.contributor.author | Sathish, T | en_US |
dc.contributor.author | Rafferty, JM | en_US |
dc.contributor.author | Rajalakshmi, R | en_US |
dc.contributor.author | Anjana, RM | en_US |
dc.contributor.author | Jebarani, S | en_US |
dc.contributor.author | Mohan, V | en_US |
dc.contributor.author | Owens, DR | en_US |
dc.contributor.author | Sivaprasad, S | en_US |
dc.date.accessioned | 2022-12-13T15:19:06Z | |
dc.date.available | 2022-07-06 | en_US |
dc.date.issued | 2022 | en_US |
dc.identifier.other | ARTN 101578 | en_US |
dc.identifier.other | ARTN 101578 | en_US |
dc.identifier.other | ARTN 101578 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/83103 | |
dc.relation.ispartof | ECLINICALMEDICINE | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | Diabetic | en_US |
dc.subject | Retinopathy | en_US |
dc.subject | Predictive models | en_US |
dc.subject | Performance | en_US |
dc.subject | Diabetes | en_US |
dc.subject | South Asians | en_US |
dc.subject | India | en_US |
dc.title | Development and validation of predictive risk models for sight threatening diabetic retinopathy in patients with type 2 diabetes to be applied as triage tools in resource limited settings | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1016/j.eclinm.2022.101578 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000907286800041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 51 | en_US |
qmul.funder | Ethnic inequalities in trajectories of cardio-metabolic risk factor control and outcomes of type two diabetes::Wellcome Trust | en_US |